Skip to main content
SINOVAC BIOTECH LTD logo

SINOVAC BIOTECH LTD — Investor Relations & Filings

Ticker · SVA ISIN · AGP8696W1045 LEI · 529900DOOGH8WKB2WL85 US Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country AG Antigua and Barbuda
Listing US SVA

About SINOVAC BIOTECH LTD

http://www.sinovac.com/

Sinovac Biotech Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. The company's portfolio includes vaccines for influenza and Hepatitis A, among others. Sinovac maintains a strong commitment to innovation, with an active R&D pipeline aimed at developing vaccines for over 20 life-threatening diseases. This research focus is supported by a significant number of patents, scientific publications, and the undertaking of numerous state and local research projects.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 88% confidence The document is clearly a Form 6-K “Report of Foreign Private Issuer” filed with the SEC for May 2026. This is a periodic regulatory filing by a foreign private issuer and contains the cover page, signature block, and exhibit index, but no substantive financial statements. Under our taxonomy, Form 6-K falls under general Regulatory Filings (RNS).
2026-05-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 90% confidence The document is a US SEC Form 6-K (“Report of Foreign Private Issuer”) filed pursuant to the Securities Exchange Act. It is a general regulatory submission (addressing compliance with Rule 13a-16 or 15d-16) and does not itself contain substantive financial statements or constitute an annual/quarterly report. It serves as a regulatory filing with an exhibit index pointing to a press release. Thus, it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-21 English
6-K - SINOVAC BIOTECH LTD (0001084201) (Filer)
Regulatory Filings Classification · 85% confidence The document is a Form 6-K “Report of Foreign Private Issuer” filed by Sinovac Biotech to furnish a correction to its previously filed annual report on Form 20-F. It does not contain substantive financial statements itself but is a regulatory compliance current report used by foreign issuers to report material events. This falls under general regulatory filings that do not fit other specific categories, so it should be classified as Regulatory Filings (RNS).
2026-05-07 English
3 - SINOVAC BIOTECH LTD (0001084201) (Issuer)
Director's Dealing
2026-03-18 English
3 - SINOVAC BIOTECH LTD (0001084201) (Issuer)
Director's Dealing
2026-03-18 English
3 - SINOVAC BIOTECH LTD (0001084201) (Issuer)
Director's Dealing
2026-03-18 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.